This guide has been written collaboratively by people with lived experience of substance use, nursing students, harm reductionists, and medical professionals to address medical issues that may affect people who use drugs. This is a helpful tool for any participant of a South Carolina syringe exchange.
White Paper
On Friday, June 9, 2023, the Prisma Health Addiction Medicine Center in Greenville, South Carolina hosted over 175 individuals from multidisciplinary backgrounds to discuss the current landscape of harm reduction services and to share ideas to foster access to these services in the state.
This white paper prepared by Jodi Manz, Clear Bell Solutions, summarizes the content delivered by expert speakers at the South Carolina Harm Reduction and Syringe Service Program Symposium.
South Carolina has the nation’s eighth-highest rate of new HIV diagnoses. Community based, nonprofit SSP proves to be one of the best methods of decreasing new HIV infection rates.
Private insurance covered only 17% of the cost of hospital-based treatment for HIV in 2018. The balance was covered by Medicare (39.5%), Medicaid (27.8%) or billed to indigent/self-pay patients (15.7%) (IMPH, 2019).
Private insurance covered only 11.6% of the cost of hospital-based treatment for HCV in 2018. The balance was covered by Medicare (37.8%), Medicaid (24.7%) or billed to indigent/self-pay patients (26%) (IMPH, 2019).
Each individual with HCV who injects drugs infects an average of 20 other people. Leading public health agencies around the globe acknowledge syringe service programs as one of the most effective measures against the spread of HCV (IMPH, 2019)
"In January 2019, the South Carolina Department of Health and Environmental Control (DHEC) received verification from the CDC that South Carolina is at high-risk for HIV and HCV outbreaks due to increased opioid use and unsafe drug injection activities in the state. This CDC response not only emphasizes the need that exists in South Carolina to fund SSPs, but also provides recommendations for implementing this effective public health intervention to address these co-occurring epidemics" (IMPH, 2019).
In South Carolina, the average lifetime cost for treating one person living with HIV is $478,000 (in 2017 dollars), whereas a new syringe costs about 10 cents...
There has been a significant increase in the cost of hospital-based treatment for HCV in South Carolina from $198.5 million in 2009 to almost $347 million in 2018.1 Again, a new syringe costs about 10 cents...
The U.S. Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and other national public health leaders view SSPs as a key component of a comprehensive strategy for combatting the nation’s opioid crisis and reducing the transmission of infectious disease, thereby saving lives and money.
What is a Community Distributor? State statute defines a Community Distributor as “an organization, either public or private, which provides substance use disorder assistance and services, such as counseling, homeless services, advocacy, harm reduction, alcohol and drug screening, and treatment to individuals at risk of experiencing an opioid-related overdose” (S.C. Code Section 44-130-20(2)).
This law protects Community Distributors from any civil liability or criminal prosecution. S.C. Code Section 44-130-70(D) provides that “A community distributor that distributes an opioid antidote in accordance with the provisions of this section is not as a result of an act or omission subject to civil or criminal liability.”
The use of Intramuscular (IM) naloxone and syringes are legal under the South Carolina Joint Protocol. Learn more the Joint Protocol and how to administer naloxone by clicking the button below.
Between 2014 and 2015, Scott County Indiana saw an HIV outbreak of over 200 new infections of HIV with a 90% Hepatitis C co occurrence rate. Since the inception of the Scott County Syringe Services Programs, there have been less than 5 new cases of HIV in preceding years. *(1)
The U.S. Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and other national public health leaders view SSPs as a key component of a comprehensive strategy for combatting the nation’s opioid crisis and reducing the transmission of infectious disease, thereby saving lives and money. SSPs are safe, effective, cost-saving, do not increase illegal drug use or crime and are frequently supported by law enforcement officials and emergency workers. There is an estimated return on investment of $7.58 for every $1 spent for non-profit SSPs. *(2)
References
(1)
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6416a4.htm
(2)
content/uploads/2019/12/PolicyBrief_OpioidEpidemicInfectiousDisease.pdf
(3)
Supplies for South Carolina syringe exchange, Challenges Inc for reducing infectious disease in SC.